About EZZ Life Science
EZZ Life Science Holdings Limited (ASX:EZZ) is a genomic life science company with a mission to improve quality of life and human health.
EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management.
EZZ is passionate about investing in the future of consumer health through the development of e-commerce and distribution of high-quality products via omnichannel models across Australia, New Zealand, China and worldwide.
Latest News
ASX ANNOUNCEMENTS
EZZ to be added to MSCI World Micro Cap Index
November 11, 2024
Appendix 3A.1 – Notification of Dividend Distribution
October 28, 2024
Final Dividend Announcement
October 28, 2024
IN THE NEWS
Investor Engagement
See how we help our investors